Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 29, 1997

View Archived Issues

Company Profile: Sugen

SS Pharm. patents new antifungal agents

New antiallergic agents from Dainippon Ink & Chemicals

Otsuka's new antidiabetic agents

FDA clears new oral treatment for hair loss in men

TOBI approved by FDA for management of CF patients

FDA approval obtained for Prandin

Teveten cleared for U.S. marketing

SAR leading to new topoisomerase I inhibitor presented by Banyu

Suntory in-licenses new antidementia agent

VRCTC-310: MTD, preliminary efficacy and pharmacokinetic data in humans

DX-9065a exhibits antithrombotic efficacy and no effects on hemostasis in animal model

Phase IIb trial of TCR vaccine for rheumatoid arthritis begins

Alferon evaluated in patients coinfected with HIV and HCV

MedImmune and BioTransplant plan to test MEDI-507 for graft-vs.-host disease

Alexion files IND for C5 inhibitor treatment for rheumatoid arthritis

NDA filed for extended-release Ditropan formulation

Triangle Pharmaceuticals plans to reinitiate trials with DMP-450

Lidak submits NDA for Lidakol

Aronex/Ferrer seek approval of Nyotran in Spain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 3, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 3, 2025.
Researchers arm CAR T cells to fight solid tumors
BioWorld
Aussie researchers have used CRISPR gene editing tools to “armor” chimeric antigen receptor (CAR) T cells to activate additional cancer-fighting proteins at the...
Bioversys, Shionogi in CHF529M lung infection collaboration
BioWorld Science
Antibiotics specialist Bioversys AG has sealed a potential CHF529 million (US$667.5 million) deal with Shionogi Co. Ltd., in which they will work together on...
Medtronic receives CE mark for its Vitalflow ECMO system
BioWorld MedTech
Medtronic plc received a CE mark for its Vitalflow extracorporeal membrane oxygenation (ECMO) system, which provides temporary support for the heart and lungs in...